Pharmaceutical Benefits Scheme limitations on macrolides: implications for pertussis management.
Kari A J
KA
Jarvinen
Bradley J
BJ
McCall
Clare B
CB
Nourse
Joe G
JG
McCormack
Martyn H
MH
Tilse
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001315:Australia; D017963:Azithromycin / Q000627:therapeutic use; D004335:Drug and Narcotic Control; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018942:Macrolides / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D015575:Roxithromycin / Q000627:therapeutic use; D014917:Whooping Cough / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D018942:Macrolides; D015575:Roxithromycin; D017963:Azithromycin